Stockreport

Artiva Biotherapeutics GAAP EPS of -$0.88 [Seeking Alpha]

Artiva Biotherapeutics, Inc.  (ARTV) 
PDF As of September 30, 2025, Artiva had cash, cash equivalents, and investments of $123.0 million, which is expected to fund operations into Q2 2027 More on Artiva Biothe [Read more]